Ocular Toxicity of Mitogen-Activated Protein Kinase Inhibitors.

Autor: Purbrick RMJ; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom2Sussex Eye Hospital, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom., Osunkunle OA; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom., Talbot DC; The Early Phase Clinical Trials Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Downes SM; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom.
Jazyk: angličtina
Zdroj: JAMA oncology [JAMA Oncol] 2017 Feb 01; Vol. 3 (2), pp. 275-277.
DOI: 10.1001/jamaoncol.2016.4213
Databáze: MEDLINE